Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Valion Bio, Inc. (VBIO) had Debt to Capital Ratio of 0.27 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-6.44M |
|
-- |
|
-- |
|
$5.63M |
|
$-5.63M |
|
$-0.59M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.22M |
|
$-6.20M |
|
$-6.22M |
|
$-5.63M |
|
$-5.01M |
|
2.88M |
|
2.88M |
|
$-2.23 |
|
$-2.23 |
|
| Balance Sheet Financials | |
$8.65M |
|
$12.64M |
|
$29.56M |
|
$38.22M |
|
$2.62M |
|
$6.90M |
|
$17.05M |
|
$19.67M |
|
$11.06M |
|
$12.85M |
|
$18.55M |
|
2.88M |
|
| Cash Flow Statement Financials | |
$-5.01M |
|
$-0.01M |
|
$-0.04M |
|
$12.64M |
|
$7.58M |
|
$-5.06M |
|
$0.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.31 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.27 |
0.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.02M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-56.27% |
|
-48.45% |
|
-16.29% |
|
-24.46% |
|
$6.44 |
|
$-1.74 |
|
$-1.74 |
|